ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2022

Concerns about subgroup analyses and reason for stopping remdesivir trial.

Bharath Kumar Tirupakuzhi VijayaraghavanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.